Ligand Pharmaceuticals Incorporated (LGND)

Debt-to-assets ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands — — — — — — — — — — — — — — — — — — — —
Total assets US$ in thousands 941,774 954,866 866,405 913,869 833,064 769,210 758,105 811,076 762,668 1,051 1,076,290 1,105,180 1,301,380 1,273,660 1,256,280 1,295,120 1,362,280 1,247,450 1,242,940 1,185,920
Debt-to-assets ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $941,774K
= 0.00

The debt-to-assets ratio for Ligand Pharmaceuticals Incorporated has been consistently at 0.00 for all the reported quarters from March 31, 2020, to December 31, 2024. This indicates that the company has not used any debt to finance its assets during this period. A debt-to-assets ratio of 0.00 means that the company's total assets are entirely financed by equity, indicating a low financial risk as there is no debt obligation to be repaid. Ligand Pharmaceuticals' financial structure appears to be conservative and stable, with a strong reliance on equity financing rather than debt.